Pantothenate biosynthesis in Toxoplasma gondii tachyzoites is not a drug target.
PanC
Pantoate β-alanine ligase
Pantothenate
Pantothenate synthetase
SW314
T. gondii
Journal
International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
20
11
2022
revised:
08
03
2023
accepted:
12
03
2023
medline:
31
7
2023
pubmed:
3
4
2023
entrez:
2
4
2023
Statut:
ppublish
Résumé
Toxoplasma gondii is a pervasive apicomplexan parasite that can cause severe disease and death in immunocompromised individuals and the developing foetus. The treatment of toxoplasmosis often leads to serious side effects and novel drugs and drug targets are therefore actively sought. In 2014, Mageed and colleagues suggested that the T. gondii pantothenate synthetase, the enzyme responsible for the synthesis of the vitamin B
Identifiants
pubmed: 37004488
pii: S2211-3207(23)00011-8
doi: 10.1016/j.ijpddr.2023.03.003
pmc: PMC10102396
pii:
doi:
Substances chimiques
Coenzyme A
SAA04E81UX
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.